Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marcia A Testa, Ph.D.

Title
Institution
Department
Address
Phone
Profile Picture

Overview
Dr. Testa and colleagues are developing quantitative and health information technology methods and processes relating to the measurement and analysis of expanded patient outcomes (quality of life, cost-effectiveness and risk-benefit) for clinical, pharmacoeconomic, pharmacoepidemiologic, quality of care and comparative effectiveness research studies with particular application to primary care, cardiovascular disease, HIV, and diabetes.
Quality of Life, Patient Satisfaction, Clinical Decision Making and Comparative Effectiveness Research
Dr. Testa is working on analytical, statistical and health information methods for conducting health outcomes and comparative effectivness research for pharmaceutical drug development, disease management, quality of care programs and primary care and physician subspecialty practice management. As part of this methodologic work, she is analyzing a comprehensive database of patients who have participated in large-scale clinical trials of antihypertensive and diabetes therapies to evaluate differential treatment effects on quality-of-life outcomes including mood, vitality, sleep, cognitive functioning, sexual dysfunctioning, work/social role functioning and physical symptoms. Dr. Testa is exploring the relationships between treatment satisfaction, glycemic control, hypo and hyperglycemic symptomatology, quality of life and health care utilization during the treatment of patients with type 1 and type 2 diabetes. For the past five years she also has worked on designing Web 2.0 and Health 2.0 home health monitoring health information systems involving the use of telemedicine and telehealth (e-Health) strategies for diabetes management.
Pharmacoeconomics and Pharmacoepidemiology
As part of the AIDS Clinical Trials Group, Dr. Testa and colleagues have evaluated the quality-of-life impact of treatment for HIV in medication adherence models. Adherence to HIV therapy has implications for the cost-effectiveness of new treatments. Dr. Testa is also currently developing database systems and electronic reporting devices (e-diaries) for monitoring health outcomes, expanding observational databases for longitudinal research and surveying resource utilization and costs for inclusion into pharmacoeconomic, pharmacoepidemiological and cost-effectivness models. She has guided doctoral research in the areas of health outcomes research and pharmacoepidemiology evaluating patient compliance, physician practice patterns and patient functional health status and quality of life using large patient information systems.
Statistical Methods for Quality-of-Life Outcomes Research
Dr. Testa and colleagues are developing more sophisticated methods for dealing with the analysis of expanded patient outcomes. The statistical and analytical issues involve applications of item response theory, causal modeling, latent variables and structural equation modeling to the analysis of quality-of-life and patient satisfaction data. Other topics of research interest include:
measurement, involving the response structure of multi-dimensional constructs, intervention and non-intervention based validities, and respondent variability;
hypothesis testing, including estimation of power, simultaneous test procedures, global hypothesis testing, longitudinal models, and the effects of missing data, early withdrawal, length bias and confounding; and
overall effectiveness models, specifically quality-adjustment measures, and health state transition and utility models.

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U90TP000417 (TESTA, MARCIA A) Sep 30, 2010 - Dec 31, 2015
    NIH
    TP10-1001, PREPAREDNESS AND EMERGENCY RESPONSE LEARNING CENTER (PERLC)
    Role: Principal Investigator
  2. R01HS007767 (TESTA, MARCIA A) Mar 1, 1993 - Feb 28, 1997
    NIH
    STATISTICAL METHODS FOR QUALITY-OF-LIFE OUTCOME RESEARCH
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Piltch-Loeb R, Harriman NW, Healey J, Bonetti M, Toffolutti V, Testa MA, Su M, Savoia E. COVID-19 Vaccine Concerns about Safety, Effectiveness, and Policies in the United States, Canada, Sweden, and Italy among Unvaccinated Individuals. Vaccines (Basel). 2021 Oct 06; 9(10). PMID: 34696245.
    Citations:    
  2. Savoia E, Piltch-Loeb R, Goldberg B, Miller-Idriss C, Hughes B, Montrond A, Kayyem J, Testa MA. Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination. Vaccines (Basel). 2021 Jul 09; 9(7). PMID: 34358184.
    Citations: 2     
  3. Piltch-Loeb R, Savoia E, Goldberg B, Hughes B, Verhey T, Kayyem J, Miller-Idriss C, Testa M. Examining the effect of information channel on COVID-19 vaccine acceptance. PLoS One. 2021; 16(5):e0251095. PMID: 33979370.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  4. Bahl NE, Magnavita ES, Hshieh T, Testa M, Kim D, Manor B, Driver JA, Abel GA, DuMontier C. Objective performance tests of cognition and physical function as part of a virtual geriatric assessment. J Geriatr Oncol. 2021 Nov; 12(8):1256-1258. PMID: 33795206.
    Citations:    Fields:    
  5. Harriman N, Shortland N, Su M, Cote T, Testa MA, Savoia E. Youth Exposure to Hate in the Online Space: An Exploratory Analysis. Int J Environ Res Public Health. 2020 11 17; 17(22). PMID: 33212999.
    Citations: 2     Fields:    Translation:Humans
  6. Frias JP, Gonzalez-Galvez G, Johnsson E, Maaske J, Testa MA, Simonson DC, Dronamraju N, Garcia-Sanchez R, Peters AL. Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial. Diabetes Obes Metab. 2020 07; 22(7):1083-1093. PMID: 32052516.
    Citations: 2     Fields:    Translation:Humans
  7. Okubo Y, Nochioka K, Testa MA. Nationwide Survey of Hospitalization Due to Pediatric Food-Induced Anaphylaxis in the United States. Pediatr Emerg Care. 2019 Nov; 35(11):769-773. PMID: 30113437.
    Citations: 1     Fields:    Translation:HumansAnimals
  8. Fozouni L, Buchheit B, Walley AY, Testa M, Chatterjee A. Public restrooms and the opioid epidemic. Subst Abus. 2020; 41(4):432-436. PMID: 31368865.
    Citations: 4     Fields:    
  9. Zhang H, Goldberg SI, Hosomura N, Shubina M, Simonson DC, Testa MA, Turchin A. Lifestyle Counseling and Long-term Clinical Outcomes in Patients With Diabetes. Diabetes Care. 2019 09; 42(9):1833-1836. PMID: 31371430.
    Citations: 1     Fields:    Translation:Humans
  10. Minegishi M, Takahashi T, Testa M. Pediatric acquired demyelinating syndrome (ADS) in inpatient hospital settings: The hospitalization rate, costs, and outcomes in the US. Mult Scler Relat Disord. 2019 Sep; 34:150-157. PMID: 31295724.
    Citations:    Fields:    Translation:Humans
  11. Epstein S, Tran BN, Capone AC, Ruan QZ, Fukudome EY, Ricci JA, Testa MA, Dennerlein JT, Lee BT, Singhal D. The Current State of Surgical Ergonomics Education in U.S. Surgical Training: A Survey Study. Ann Surg. 2019 04; 269(4):778-784. PMID: 29381528.
    Citations: 4     Fields:    
  12. Savoia E, Guicciardi S, Bernard DP, Harriman N, Leinhos M, Testa M. Preparedness Emergency Response Research Centers (PERRCs): Addressing Public Health Preparedness Knowledge Gaps Using a Public Health Systems Perspective. Am J Public Health. 2018 11; 108(S5):S363-S365. PMID: 30422694.
    Citations:    Fields:    Translation:Humans
  13. de Silva PS, O'Toole A, Marc LG, Ulysse CA, Testa MA, Julsgaard M, Ngyuen D, Ananthakrishnan A, Laursen T, Højgaard A, Christensen LA, Korzenik J, Friedman S. Development of a Sexual Dysfunction Scale for Women With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018 10 12; 24(11):2350-2359. PMID: 30165525.
    Citations: 3     Fields:    Translation:Humans
  14. Testa MA, Savoia E, Su M, Biddinger PD. Social Media Learning Collaborative for Public Health Preparedness. Am J Public Health. 2018 11; 108(S5):S375-S377. PMID: 30260697.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  15. Turchin A, Sosina O, Zhang H, Shubina M, Desai SP, Simonson DC, Testa MA. Ambulatory Medication Reconciliation and Frequency of Hospitalizations and Emergency Department Visits in Patients With Diabetes. Diabetes Care. 2018 08; 41(8):1639-1645. PMID: 29891639.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  16. O'Toole A, de Silva PS, Marc LG, Ulysse CA, Testa MA, Ting A, Moss A, Korzenik J, Friedman S. Sexual Dysfunction in Men With Inflammatory Bowel Disease: A New IBD-Specific Scale. Inflamm Bowel Dis. 2018 01 18; 24(2):310-316. PMID: 29361102.
    Citations: 7     Fields:    Translation:Humans
  17. Okubo Y, Nochioka K, Testa M. Nationwide survey of pediatric acute osteomyelitis in the USA. J Pediatr Orthop B. 2017 Nov; 26(6):501-506. PMID: 28230612.
    Citations: 5     Fields:    Translation:Humans
  18. Okubo Y, Nochioka K, Testa MA. The impact of pediatric obesity on hospitalized children with lower respiratory tract infections in the United States. Clin Respir J. 2018 Apr; 12(4):1479-1484. PMID: 28842971.
    Citations: 7     Fields:    Translation:Humans
  19. Ouchi K, Hohmann S, Goto T, Ueda P, Aaronson EL, Pallin DJ, Testa MA, Tulsky JA, Schuur JD, Schonberg MA. Index to Predict In-hospital Mortality in Older Adults after Non-traumatic Emergency Department Intubations. West J Emerg Med. 2017 Jun; 18(4):690-697. PMID: 28611890.
    Citations: 2     Fields:    Translation:Humans
  20. Okubo Y, Nochioka K, Testa MA. Nationwide Survey of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children in the United States. Pediatr Dermatol. 2017 Mar; 34(2):206-208. PMID: 27990674.
    Citations:    Fields:    Translation:Humans
  21. Okubo Y, Nochioka K, Sakakibara H, Testa M, Sundel RP. National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA. Clin Rheumatol. 2017 Feb; 36(2):413-419. PMID: 27987089.
    Citations: 11     Fields:    Translation:Humans
  22. Okubo Y, Nochioka K, Sakakibara H, Hataya H, Terakawa T, Testa M, Sundel RP. Nationwide epidemiological survey of childhood IgA vasculitis associated hospitalization in the USA. Clin Rheumatol. 2016 Nov; 35(11):2749-2756. PMID: 27596741.
    Citations: 5     Fields:    Translation:Humans
  23. Jendle J, Testa MA, Martin S, Jiang H, Milicevic Z. Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy. Diabetes Obes Metab. 2016 10; 18(10):999-1005. PMID: 27279266.
    Citations: 6     Fields:    Translation:Humans
  24. Okubo Y, Nochioka K, Hataya H, Sakakibara H, Terakawa T, Testa M. Burden of Obesity on Pediatric Inpatients with Acute Asthma Exacerbation in the United States. J Allergy Clin Immunol Pract. 2016 Nov - Dec; 4(6):1227-1231. PMID: 27372599.
    Citations: 19     Fields:    Translation:Humans
  25. DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, Hu FB, Kahn CR, Raz I, Shulman GI, Simonson DC, Testa MA, Weiss R. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015 07 23; 1:15019. PMID: 27189025.
    Citations: 220     Fields:    Translation:HumansCells
  26. Doshi-Velez F, Marshall YE, Testa MA, Su M, Konate S, Torres J, Savoia E. et al. . HackEbola with Data: On the hackathon format for timely data analysis. Procedia Engineering. 2015; (107):377 - 386.
  27. Testa MA, Pettigrew ML, Savoia E. Measurement, geospatial, and mechanistic models of public health hazard vulnerability and jurisdictional risk. J Public Health Manag Pract. 2014 Sep-Oct; 20 Suppl 5:S61-8. PMID: 25072492.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  28. Marc LG, Henderson WR, Desrosiers A, Testa MA, Jean SE, Akom EE. Reliability and validity of the Haitian Creole PHQ-9. J Gen Intern Med. 2014 Dec; 29(12):1679-86. PMID: 25092004.
    Citations: 12     Fields:    Translation:Humans
  29. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB, Dworkin LD. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014 Jan 02; 370(1):13-22. PMID: 24245566.
    Citations: 213     Fields:    Translation:Humans
  30. Turner RR, Testa MA, Hayes JF, Su M. Validation of the allergic rhinitis treatment satisfaction and preference scale. Allergy Asthma Proc. 2013 Nov-Dec; 34(6):551-7. PMID: 24079817.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  31. Robbins GK, Testa MA, Su M, Safren SA, Morse G, Lammert S, Shafer RW, Reynolds NR, Chesney MA. Site nurse-initiated adherence and symptom support telephone calls for HIV-positive individuals starting antiretroviral therapy, ACTG 5031: substudy of ACTG 384. HIV Clin Trials. 2013 Sep-Oct; 14(5):235-53. PMID: 24144900.
    Citations: 8     Fields:    Translation:Humans
  32. Nanda A, Khan IS, Goldman R, Testa M. Sports-related concussions and the Louisiana Youth Concussion Act. J La State Med Soc. 2012 Sep-Oct; 164(5):246-50. PMID: 23362587.
    Citations:    Fields:    Translation:Humans
  33. Testa MA, Gill J, Su M, Turner RR, Blonde L, Simonson DC. Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: a randomized, controlled, crossover trial. J Clin Endocrinol Metab. 2012 Oct; 97(10):3504-14. PMID: 22851487.
    Citations: 14     Fields:    Translation:Humans
  34. Savoia E, Testa MA, Viswanath K. Predictors of knowledge of H1N1 infection and transmission in the U.S. population. BMC Public Health. 2012 May 03; 12:328. PMID: 22554124.
    Citations: 7     Fields:    Translation:HumansCells
  35. Marc LG, Wang MM, Testa MA. Psychometric evaluation of the HIV symptom distress scale. AIDS Care. 2012; 24(11):1432-41. PMID: 22409246.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  36. Bailey EE, Marghoob AA, Orengo IF, Testa MA, White VR, Geller AC. Skin cancer knowledge, attitudes, and behaviors in the salon: a survey of working hair professionals in Houston, Texas. Arch Dermatol. 2011 Oct; 147(10):1159-65. PMID: 22006132.
    Citations: 8     Fields:    Translation:Humans
  37. Marc LG, Zerden M, Ferrando SJ, Testa MA. HIV+ caregivers and HIV+ non-caregivers: differences in sociodemographics, immune functioning, and quality-of-life. AIDS Care. 2011 Jul; 23(7):880-91. PMID: 21400310.
    Citations: 3     Fields:    Translation:Humans
  38. Henderson E, Testa MA, Hartnick C. Prevalence of noise-induced hearing-threshold shifts and hearing loss among US youths. Pediatrics. 2011 Jan; 127(1):e39-46. PMID: 21187306.
    Citations: 53     Fields:    Translation:HumansPHPublic Health
  39. Bode BW, Testa MA, Magwire M, Hale PM, Hammer M, Blonde L, Garber A. Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes. Diabetes Obes Metab. 2010 Jul; 12(7):604-12. PMID: 20590735.
    Citations: 22     Fields:    Translation:Humans
  40. Savoia E, Testa MA, Biddinger PD, Cadigan RO, Koh H, Campbell P, Stoto MA. Assessing public health capabilities during emergency preparedness tabletop exercises: reliability and validity of a measurement tool. Public Health Rep. 2009 Jan-Feb; 124(1):138-48. PMID: 19413036.
    Citations: 7     Fields:    Translation:Humans
  41. Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA. The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol. 2008 Mar; 35(3):387-93. PMID: 18260176.
    Citations: 83     Fields:    Translation:Humans
  42. Reynolds NR, Testa MA, Su M, Chesney MA, Neidig JL, Frank I, Smith S, Ickovics J, Robbins GK. Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. . 2008 Jan 01; 47(1):62-8. PMID: 17891043.
    Citations: 46     Translation:Humans
  43. Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum. 2007 Dec 15; 57(8):1431-8. PMID: 18050184.
    Citations: 81     Fields:    Translation:Humans
  44. Marc LG, Testa MA, Walker AM, Robbins GK, Shafer RW, Anderson NB, Berkman LF. Educational attainment and response to HAART during initial therapy for HIV-1 infection. J Psychosom Res. 2007 Aug; 63(2):207-16. PMID: 17662759.
    Citations: 11     Fields:    Translation:HumansCells
  45. Dorn BC, Savoia E, Testa MA, Stoto MA, Marcus LJ. Development of a survey instrument to measure connectivity to evaluate national public health preparedness and response performance. Public Health Rep. 2007 May-Jun; 122(3):329-38. PMID: 17518304.
    Citations: 4     Fields:    Translation:Humans
  46. Testa MA, Simonson DC. Satisfaction and quality of life with premeal inhaled versus injected insulin in adolescents and adults with type 1 diabetes. Diabetes Care. 2007 Jun; 30(6):1399-405. PMID: 17337493.
    Citations: 7     Fields:    Translation:Humans
  47. Meaney PA, Nadkarni VM, Cook EF, Testa M, Helfaer M, Kaye W, Larkin GL, Berg RA. Higher survival rates among younger patients after pediatric intensive care unit cardiac arrests. Pediatrics. 2006 Dec; 118(6):2424-33. PMID: 17142528.
    Citations: 50     Fields:    Translation:Humans
  48. Straus DJ, Testa MA, Sarokhan BJ, Czuczman MS, Tulpule A, Turner RR, Riggs SA. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies. Cancer. 2006 Oct 15; 107(8):1909-17. PMID: 16977654.
    Citations: 12     Fields:    Translation:Humans
  49. Beal AC, Chou SC, Palmer RH, Testa MA, Newman C, Ezhuthachan S. The changing face of race: risk factors for neonatal hyperbilirubinemia. Pediatrics. 2006 May; 117(5):1618-25. PMID: 16651315.
    Citations: 5     Fields:    Translation:Humans
  50. Fletcher CV, Testa MA, Brundage RC, Chesney MA, Haubrich R, Acosta EP, Martinez A, Jiang H, Gulick RM. Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359. . 2005 Nov 01; 40(3):301-6. PMID: 16249704.
    Citations: 28     Translation:HumansCellsCTClinical Trials
  51. Palmer RH, Ezhuthachan S, Newman C, Maisels MJ, Testa MA. Management of hyperbilirubinemia in newborns: measuring performance using a benchmarking model. Pediatrics. 2004 Sep; 114(3):902. PMID: 15342881.
    Citations: 1     Fields:    Translation:Humans
  52. Palmer RH, Ezhuthachan S, Newman C, Maisels MJ, Testa MA. Hyperbilirubinemia benchmarking. Pediatrics. 2004 Sep; 114(3):902-4. PMID: 15342882.
    Citations:    Fields:    Translation:Humans
  53. Reynolds NR, Testa MA, Marc LG, Chesney MA, Neidig JL, Smith SR, Vella S, Robbins GK. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study. AIDS Behav. 2004 Jun; 8(2):141-50. PMID: 15187476.
    Citations: 76     Fields:    Translation:HumansCTClinical Trials
  54. Savoia E, Morano J, Cote D, Rampal S, Villa D, Testa MA. . Public health preparedness evaluation and measurement. 2004;1(1-2):56. Italian Journal of Public Health. 2004; 1-2(1):56.
  55. Chou SC, Palmer RH, Ezhuthachan S, Newman C, Pradell-Boyd B, Maisels MJ, Testa MA. Management of hyperbilirubinemia in newborns: measuring performance by using a benchmarking model. Pediatrics. 2003 Dec; 112(6 Pt 1):1264-73. PMID: 14654595.
    Citations: 9     Fields:    Translation:Humans
  56. Yang CC, Jick SS, Testa MA. Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics. Br J Clin Pharmacol. 2003 Jul; 56(1):84-91. PMID: 12848779.
    Citations: 11     Fields:    Translation:Humans
  57. Yang CC, Jick SS, Testa MA. Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation. Br J Clin Pharmacol. 2003 Mar; 55(3):288-98. PMID: 12630980.
    Citations: 9     Fields:    Translation:Humans
  58. Testa MA. Improving diabetes therapy: Improving satisfaction. Diabetes Voice. 2003; (48):23-25.
  59. Miles SA, Testa M, Huang J, Wade M, Carden J, Scadden DT. Lack of antitumor activity and intolerance of interleukin-4 in patients with advanced HIV disease and Kaposi's sarcoma. J Interferon Cytokine Res. 2002 Nov; 22(11):1143-8. PMID: 12513914.
    Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
  60. Evans SR, Krown SE, Testa MA, Cooley TP, Von Roenn JH. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study. J Clin Oncol. 2002 Aug 01; 20(15):3236-41. PMID: 12149296.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  61. Krown SE, Li P, Von Roenn JH, Paredes J, Huang J, Testa MA. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study. J Interferon Cytokine Res. 2002 Mar; 22(3):295-303. PMID: 12034036.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  62. Bacon CG, Giovannucci E, Testa M, Glass TA, Kawachi I. The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Cancer. 2002 Feb 01; 94(3):862-71. PMID: 11857323.
    Citations: 35     Fields:    Translation:Humans
  63. Bacon CG, Giovannucci E, Testa M, Kawachi I. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol. 2001 Nov; 166(5):1804-10. PMID: 11586228.
    Citations: 21     Fields:    Translation:Humans
  64. Testa MA. Methods and applications of quality-of-life measurement during antihypertensive therapy. Curr Hypertens Rep. 2000 Dec; 2(6):530-7. PMID: 11062598.
    Citations: 4     Fields:    Translation:Humans
  65. Langley PC, Testa MA. Can you measure the quality of this life? Interview by Lauren M. Walker. Bus Health. 2000 Oct; 18(9):42-4, 47-8. PMID: 11141794.
    Citations:    Fields:    Translation:Humans
  66. Testa MA. Interpretation of quality-of-life outcomes: issues that affect magnitude and meaning. Med Care. 2000 Sep; 38(9 Suppl):II166-74. PMID: 10982103.
    Citations: 24     Fields:    Translation:Humans
  67. Turner RR, Testa MA. Measuring the impact of onychomycosis on patient quality of life. Qual Life Res. 2000 Feb; 9(1):39-53. PMID: 10981205.
    Citations: 9     Fields:    Translation:Humans
  68. Testa MA. . Quality -of-Life Assessment in diabetes research: Interpreting the magnitude and meaning of treatment effects. Diabetes Spectrum. 2000; (13):29-35.
  69. Blonde L, Dey J, Testa MA, Guthrie RD. Defining and measuring quality of diabetes care. Prim Care. 1999 Dec; 26(4):841-55. PMID: 10523463.
    Citations: 4     Fields:    Translation:Humans
  70. Rabkin CS, Testa MA, Huang J, Von Roenn JH. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants. . 1999 Aug 01; 21 Suppl 1:S31-3. PMID: 10430216.
    Citations: 6     Translation:Humans
  71. Lenderking WR, Tennen H, Nackley JF, Hale MS, Turner RR, Testa MA. The effects of venlafaxine on social activity level in depressed outpatients. J Clin Psychiatry. 1999 Mar; 60(3):157-63. PMID: 10192590.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  72. Testa MA, Lenderking WR. The impact of AIDS-associated wasting on quality of life: qualitative issues of measurement and evaluation. J Nutr. 1999 01; 129(1S Suppl):282S-289S. PMID: 9915916.
    Citations: 1     Fields:    Translation:Humans
  73. Testa MA, Turner RR, Simonson DC, Krafcik MB, Calvo C, Luque-Otero M. Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain. Gastrointestinal Therapeutic System. J Hypertens. 1998 Dec; 16(12 Pt 1):1839-47. PMID: 9869019.
    Citations: 7     Fields:    Translation:Humans
  74. Testa MA, Simonson DC, Turner RR. Valuing quality of life and improvements in glycemic control in people with type 2 diabetes. Diabetes Care. 1998 Dec; 21 Suppl 3:C44-52. PMID: 9850489.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  75. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA. 1998 Nov 04; 280(17):1490-6. PMID: 9809729.
    Citations: 74     Fields:    Translation:HumansCTClinical Trials
  76. Straus DJ, Huang J, Testa MA, Levine AM, Kaplan LD. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases. J Clin Oncol. 1998 Nov; 16(11):3601-6. PMID: 9817281.
    Citations: 20     Fields:    Translation:HumansCTClinical Trials
  77. Carroll J, Testa MA, Erat K, LeBoff MS. Modeling fracture risk using bone density, age, and years since menopause. Am J Prev Med. 1997 Nov-Dec; 13(6):447-52. PMID: 9415791.
    Citations: 3     Fields:    Translation:Humans
  78. Krown SE, Testa MA, Huang J. AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol. 1997 Sep; 15(9):3085-92. PMID: 9294471.
    Citations: 58     Fields:    Translation:Humans
  79. Lenderking WR, Testa MA, Katzenstein D, Hammer S. Measuring quality of life in early HIV disease: the modular approach. Qual Life Res. 1997 Aug; 6(6):515-30. PMID: 9330552.
    Citations: 24     Fields:    Translation:Humans
  80. Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP, Herndier B, Northfelt DW, Huang J, Tulpule A, Levine AM. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med. 1997 Jun 05; 336(23):1641-8. PMID: 9171066.
    Citations: 45     Fields:    Translation:HumansCTClinical Trials
  81. Testa MA. The medical outcomes study. JAMA. 1996 Apr 10; 275(14):1083; author reply 1084-5. PMID: 8601917.
    Citations:    Fields:    Translation:Humans
  82. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996 03 28; 334(13):835-40. PMID: 8596551.
    Citations: 395     Fields:    Translation:Humans
  83. Lenderking WR, Nackley JF, Anderson RB, Testa MA. A review of the quality-of-life aspects of urinary urge incontinence. Pharmacoeconomics. 1996 Jan; 9(1):11-23. PMID: 10160084.
    Citations: 14     Fields:    Translation:Humans
  84. Fuleihan GE, Testa MA, Angell JE, Porrino N, Leboff MS. Reproducibility of DXA absorptiometry: a model for bone loss estimates. J Bone Miner Res. 1995 Jul; 10(7):1004-14. PMID: 7484275.
    Citations: 13     Fields:    Translation:Humans
  85. Andrade SE, Walker AM, Gottlieb LK, Hollenberg NK, Testa MA, Saperia GM, Platt R. Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med. 1995 Apr 27; 332(17):1125-31. PMID: 7700285.
    Citations: 76     Fields:    Translation:Humans
  86. Anderson RB, Nackley JF, Testa MA . Symptom distress check lists as a component of quality of life measurement: Comparing symptom reports with responses to multiple choice questionnaires. Drug Information Journal. 1995; 1689S-1707S.
  87. Lenderking WR, Gelber RD, Cotton DJ, Cole BF, Goldhirsch A, Volberding PA, Testa MA. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group. N Engl J Med. 1994 Mar 17; 330(11):738-43. PMID: 7906386.
    Citations: 28     Fields:    Translation:HumansCellsCTClinical Trials
  88. Parker JD, Testa MA, Jimenez AH, Tofler GH, Muller JE, Parker JO, Stone PH. Morning increase in ambulatory ischemia in patients with stable coronary artery disease. Importance of physical activity and increased cardiac demand. Circulation. 1994 Feb; 89(2):604-14. PMID: 8313548.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  89. Testa MA, Nackley JF. Methods for quality-of-life studies. Annu Rev Public Health. 1994; 15:535-59. PMID: 8054098.
    Citations: 18     Fields:    Translation:Humans
  90. Ruggieri G, Spinelli C, D'Adamo G, Franceschelli L, Testa MA. [Nutritional status of CAPD patients in Lazio]. Riv Eur Sci Med Farmacol. 1993 May-Aug; 15(3-4):149-53. PMID: 7761661.
    Citations:    Fields:    Translation:Humans
  91. Testa MA, Anderson RB, Nackley JF, Hollenberg NK. Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group. N Engl J Med. 1993 Apr 01; 328(13):907-13. PMID: 8446137.
    Citations: 44     Fields:    Translation:HumansCTClinical Trials
  92. Testa MA. Parallel perspectives on quality of life during antihypertensive therapy: impact of responder, survey environment, and questionnaire structure. J Cardiovasc Pharmacol. 1993; 21 Suppl 2:S18-25. PMID: 7692146.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  93. Testa MA, Lenderking WR. Interpreting pharmacoeconomic and quality-of-life clinical trial data for use in therapeutics. Pharmacoeconomics. 1992 Aug; 2(2):107-17. PMID: 10146951.
    Citations: 6     Fields:    Translation:Humans
  94. Gelber RD, Lenderking WR, Cotton DJ, Cole BF, Fischl MA, Goldhirsch A, Testa MA. Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials Group. Ann Intern Med. 1992 Jun 15; 116(12 Pt 1):961-6. PMID: 1586104.
    Citations: 20     Fields:    Translation:HumansCTClinical Trials
  95. Testa MA, Hollenberg NK, Anderson RB, Williams GH. Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system. Am J Hypertens. 1991 Apr; 4(4 Pt 1):363-73. PMID: 2059396.
    Citations: 19     Fields:    Translation:HumansCTClinical Trials
  96. Schoenberger JA, Testa M, Ross AD, Brennan WK, Bannon JA. Efficacy, safety, and quality-of-life assessment of captopril antihypertensive therapy in clinical practice. Arch Intern Med. 1990 Feb; 150(2):301-6. PMID: 2405803.
    Citations: 5     Fields:    Translation:Humans
  97. Testa MA, Sudilovsky A, Rippey RM, Williams GH. A short form for clinical assessment of quality of life among hypertensive patients. Am J Prev Med. 1989 Mar-Apr; 5(2):82-9. PMID: 2659046.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  98. Sudilovsky A, Croog S, Crook T, Turnbull B, Testa M, Levine S, Klerman GL. Differential effects of antihypertensive medications on cognitive functioning. Psychopharmacol Bull. 1989; 25(1):133-8. PMID: 2772112.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  99. Spackman TJ, Peccei R, Testa MA. Commercial research and development in times of financial restraint. Invest Radiol. 1988 Oct; 23(10):791-4. PMID: 3192401.
    Citations:    Fields:    
  100. Diabetic retinopathy after two years of intensified insulin treatment. Follow-up of the Kroc Collaborative Study. The Kroc Collaborative Study Group. JAMA. 1988 Jul 01; 260(1):37-41. PMID: 2898025.
    Citations: 22     Fields:    Translation:HumansCTClinical Trials
  101. Williams GH and Testa MA 1988:3 (Supplement 1);577 581. Quality of life and its assessment in treating hypertension. Current Opinion in Cardiology. 1988; Supp 1(3):577 - 581.
  102. Pinkerton RE, Garibaldi RA, Conrad C, Bush F, Brown DH, Testa MA, Gallo SJ, Lerer TJ, Ryan R, Aukerman G, et al. Urinary tract symptoms: microbiologic evaluation in rural family practice. J Am Board Fam Pract. 1988 Jan-Mar; 1(1):39-45. PMID: 3414387.
    Citations: 1     Fields:    Translation:HumansCells
  103. Testa MA, Simonson DC. Measuring quality of life in hypertensive patients with diabetes. Postgrad Med J. 1988; 64 Suppl 3:50-8; discussion 90-2. PMID: 3249717.
    Citations: 9     Fields:    Translation:Humans
  104. Levine S, Croog SH, Sudilovsky A, Testa MA. Effects of antihypertensive medications on vitality and well-being. J Fam Pract. 1987 Oct; 25(4):357-63. PMID: 3309131.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  105. Testa MA. Interpreting quality-of-life clinical trial data for use in the clinical practice of antihypertensive therapy. J Hypertens Suppl. 1987 Feb; 5(1):S9-13. PMID: 3553497.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  106. Croog SH, Sudilovsky A, Levine S, Testa MA. Work performance, absenteeism and antihypertensive medications. J Hypertens Suppl. 1987 Feb; 5(1):S47-54. PMID: 3553496.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  107. Williams GH, Croog SH, Levine S, Testa MA, Sudilovsky A. Impact of antihypertensive therapy on quality of life: effect of hydrochlorothiazide. J Hypertens Suppl. 1987 Feb; 5(1):S29-35. PMID: 3553493.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  108. Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, Klerman GL, Williams GH. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986 Jun 26; 314(26):1657-64. PMID: 3520318.
    Citations: 233     Fields:    Translation:HumansCTClinical Trials
  109. Peterson MG, Testa MA. Rank order scaling in taste evaluation. Comput Biomed Res. 1986 Feb; 19(1):56-62. PMID: 3753915.
    Citations:    Fields:    Translation:Humans
  110. Testa MA, Puklin JE, Sherwin RS, Simonson DC. Clinical predictors of retinopathy and its progression in patients with type I diabetes during CSII or conventional insulin treatment. Diabetes. 1985 Aug; 34 Suppl 3:61-8. PMID: 3894129.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  111. Kohner EM, Lawson PM, Ghosh G, Testa M. Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. Assessment of fluorescein angiograms. Diabetes. 1985 Aug; 34 Suppl 3:56-60. PMID: 4018421.
    Citations: 3     Fields:    Translation:Humans
  112. Passas CM, Wong RL, Peterson M, Testa MA, Rothfield NF. A comparison of the specificity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1985 Jun; 28(6):620-3. PMID: 4004972.
    Citations: 5     Fields:    Translation:Humans
  113. Testa MA, Simonson DC. The design and structure of clinical research information systems. Implications for data retrieval and statistical analyses. J Med Syst. 1985 Jun; 9(3):109-19. PMID: 3840516.
    Citations: 1     Fields:    Translation:Humans
  114. Bartlett RC, Mazens MF, Testa MA. Differentiation of Pseudomonas aeruginosa and Enterobacteriaceae in direct smears based on measurements by scanning electron microscopy. Diagn Microbiol Infect Dis. 1985 Mar; 3(2):143-7. PMID: 3919992.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  115. Lundy J, Thor A, Maenza R, Schlom J, Forouhar F, Testa M, Kufe D. Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients. Breast Cancer Res Treat. 1985; 5(3):269-76. PMID: 2992647.
    Citations: 9     Fields:    Translation:Humans
  116. Catalanotto FA, Dore-Duffy P, Donaldson JO, Testa M, Peterson M, Ostrom KM. Quality-specific taste changes in multiple sclerosis. Ann Neurol. 1984 Nov; 16(5):611-5. PMID: 6508242.
    Citations: 2     Fields:    Translation:Humans
  117. Tanzer JM, Börjesson AC, Laskowski L, Kurasz AB, Testa M. Glucose-sucrose-potassium tellurite-bacitracin agar, an alternative to mitis salivarius-bacitracin agar for enumeration of Streptococcus mutans. J Clin Microbiol. 1984 Oct; 20(4):653-9. PMID: 6490852.
    Citations: 9     Fields:    Translation:HumansCells
  118. Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial. N Engl J Med. 1984 08 09; 311(6):365-72. PMID: 6377076.
    Citations: 61     Fields:    Translation:HumansCTClinical Trials
  119. Levin RE, Weinstein A, Peterson M, Testa MA, Rothfield NF. A comparison of the sensitivity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1984 May; 27(5):530-8. PMID: 6721885.
    Citations: 7     Fields:    Translation:Humans
  120. Dore-Duffy P, Catalanotto F, Donaldson JO, Ostrom KM, Testa MA. Zinc in multiple sclerosis. Ann Neurol. 1983 Oct; 14(4):450-4. PMID: 6195958.
    Citations: 8     Fields:    Translation:HumansCells
  121. Gettinger G, Patters MR, Testa MA, Löe H, Anerud A, Boysen H, Robertson PB. The use of six selected teeth in population measures of periodontal status. J Periodontol. 1983 Mar; 54(3):155-9. PMID: 6573472.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  122. Cieplinski W, Reardon P, Testa MA. Non-random human chromosome distribution in human-mouse myeloma somatic cell hybrids. Cytogenet Cell Genet. 1983; 35(2):93-9. PMID: 6851676.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  123. Krishnamohan VK, Wheeler MB, Testa MA, Philipps AF. Correlation of postnatal regression of the anterior vascular capsule of the lens to gestational age. J Pediatr Ophthalmol Strabismus. 1982 Jan-Feb; 19(1):28-32. PMID: 7069563.
    Citations: 1     Fields:    Translation:Humans
  124. Holmes G, Rowe J, Hafford J, Schmidt R, Testa M, Zimmerman A. Prognostic value of the electroencephalogram in neonatal asphyxia. Electroencephalogr Clin Neurophysiol. 1982 Jan; 53(1):60-72. PMID: 6173201.
    Citations: 24     Fields:    Translation:Humans
  125. Pearson E, Garibotti JJ, Testa MA. [Mallory-Weiss syndrome]. Rev Fac Cien Med Univ Nac Cordoba. 1981 Jan-Dec; 39(1-4):17-9. PMID: 6982491.
    Citations:    Fields:    Translation:Humans
  126. Testa MA, Meigs JW. Mathematical modeling of cancer incidence rates: linear models of colon cancer in Connecticut. J Chronic Dis. 1980; 33(11-12):733-43. PMID: 7430325.
    Citations: 2     Fields:    Translation:Humans
  127. Desiderato O, Testa M. Shock-stress, gastric secretion and habituation in the chronic gastric fistula rat. Physiol Behav. 1976 Jan; 16(1):67-73. PMID: 944928.
    Citations: 2     Fields:    Translation:HumansAnimals
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Testa's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (522)
Explore
_
Co-Authors (55)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.